Kaitlin Ugolik Bayer’s Monsanto Deal Highlights Genetic Engineering Opportunities German pharmaceuticals giant Bayer’s $66 billion acquisition of Monsanto is about more than just seeds. Kaitlin Ugolik September 14, 2016